Emphysema Completed Phase 3 Trials for Arformoterol (DB01274)

Also known as: Bullous emphysema (lung)(pulmonary) / Pulmonary Emphysema / Emphysema pulmonary

IndicationStatusPhase
DBCOND0019688 (Emphysema)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00064415To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDTreatment
NCT00064402Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDTreatment
NCT00250679Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary DiseaseTreatment